MiNK Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel, first-in-class invariant natural killer T (iNKT) cell therapies to transform the lives of patients with cancer.
Events and Presentations
November 9, 2023 at 8:30 AM EST
September 13, 2023 at 2:30 PM EDT
September 12, 2023 at 12:15 PM EDT